Esperion Therapeutics
ESPR
#7071
Rank
โ‚ฌ0.30 B
Marketcap
1,58ย โ‚ฌ
Share price
0.57%
Change (1 day)
36.72%
Change (1 year)

Esperion Therapeutics (ESPR) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚ฌ0.62 B

According to Esperion Therapeutics's latest financial reports the company's total liabilities are โ‚ฌ0.62 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ0.59 B12.15%
2022-12-31โ‚ฌ0.53 B4.81%
2021-12-31โ‚ฌ0.50 B38.32%
2020-12-31โ‚ฌ0.36 B112.23%
2019-12-31โ‚ฌ0.17 B208.44%
2018-12-31โ‚ฌ56.15 M103.3%
2017-12-31โ‚ฌ27.62 M74.92%
2016-12-31โ‚ฌ15.79 M107.39%
2015-12-31โ‚ฌ7.61 M-4.66%
2014-12-31โ‚ฌ7.98 M162.51%
2013-12-31โ‚ฌ3.04 M-83.72%
2012-12-31โ‚ฌ18.68 M194.68%
2011-12-31โ‚ฌ6.34 M
2002-12-31โ‚ฌ12.11 M-9.65%
2001-12-31โ‚ฌ13.4 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ1.07 B 70.27%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.60 B 155.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ115.70 B 18,307.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ7.11 B 1,031.45%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.55 B-11.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.12 B-80.85%๐Ÿ‡บ๐Ÿ‡ธ USA